Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

TargeGen

TargeGen, Inc., a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target.

Acquired by Sanofi Aventis on June 30, 2010

Website: https://www.targegen.com

Founded: January 01, 2002

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
MDacne	Healthcare Equipment & Services	Treating Acne Was never this Easy - MDAlgorithms developed a Mobile App platform to di ...
MYHIXEL	Healthcare Equipment & Services	Working to improve male sexual wellness - MYHIXEL is a leading brand in male sexual health. ...

View more competitors»

Date	Round	Amount	Investors
Sep 21, 2009	Debt Financing	$ 3,728,379
Jul 12, 2007	Series D	$ 40,000,000	CTI Life Sciences Fund Hambrecht & Quist Capital Management Chicago Growth Partners Innovis Investments Forward Ventures Vantagepoint Capital Partners BB Biotech Ventures Pappas Ventures Enterprise Partners
Sep 26, 2005	Series C	$ 29,990,000	William Blair Forward Ventures Enterprise Partners BB Biotech Ventures

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Arda Minocherhomjee	Director	Unknown to Present
Peter G. Ulrich	Founder	Unknown to Unknown